CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Moderna, Inc.'s Q2 2025 earnings highlight a steep revenue decline post-pandemic, with just $0.1bn in revenue and a $(0.8bn) ...

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

Multiple Massachusetts-based vaccine companies, including Moderna, are affected by U.S. Health and Human Services Secretary ...

The US Department of Health and Human Services has planned to cancel $500 million in funding for mRNA vaccines, citing ...

Neither UTMB nor Moderna has confirmed the nature of the project included in the announcement, or how much funding is being ...

HHS canceled federal funding for mRNA vaccine development. Experts said this could affect our preparedness for future pandemics and innovations like cancer vaccines.

HHS Secretary Robert F. Kennedy Jr. says the federal government is calling off around $500 million worth of vaccine ...

The Health and Human Services secretary canceled nearly $500 million in contracts related to the development of future ...

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

The targeting of the vaccine technology once considered revolutionary follows intense criticism by conservatives and ...